CLINICAL_TRIALS
trial_result
· 2023-12-13
Clinical Trial Update: Smith-Lemli-Opitz Syndrome and Cholic Acid [Phase 1, Phase 2]
Summary
Phase 1/2 trial of cholic acid in Smith-Lemli-Opitz Syndrome has completed and results were posted on 2023-12-13.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Nebraska | Conditions: Smith-Lemli-Opitz Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-12-13